Zomedica ZOMDF
OTC ZOMDF
$0.08 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zomedica (ZOMDF) Asset Writedowns and Impairment (2020 - 2025)

Updated

Zomedica (ZOMDF) recorded Asset Writedowns and Impairment of $55.83 million in FY2025, up 248.4% from $16.02 million in FY2024.

Analysis

Zomedica (ZOMDF) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

Starting with FY2020, Zomedica's Asset Writedowns and Impairment history includes 4 years.

  • Annual Asset Writedowns and Impairment has a five-year compound annual growth rate of 293.6% (FY2020 to FY2025).
  • Per Business Quant data, ZOMDF's Asset Writedowns and Impairment was $16.02 million in FY2024 (+37.2%) and $11.68 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Zomedica 78.40 Mn -119.63 Mn 6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 55.83 Mn
Jun 30, 2024 16.02 Mn
Mar 31, 2020 59,097.00
API Access

Zomedica Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY